Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.15
-0.06 (-4.96%)
Market open: Aug 12, 2026, 1:59 PM EDT
1.21
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
| Name | Position |
|---|---|
| Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D. | President, CEO & Director |
| Dr. William K. Sietsema Ph.D. | Vice President of Global Regulatory Affairs |
| Mr. Gregory S. Berkin | Chief Information & Data Protection Officer |
| Mr. James Nisco | Senior VP of Finance, Treasurer, CAO & Principal Financial and Accounting Officer |
| Mr. John D. Menditto | Vice President of Investor Relations & Corporate Communications |
| Mr. Tariq Imam | Head of Human Resources, Senior VP of Business Development & Operations and General Counsel |
| Date | Type | Document |
|---|---|---|
| 2026-08-06 | 10-Q | lsta-20260630.htm |
| 2026-08-04 | 8-K | ef20079399_8k.htm |
| 2026-07-24 | 8-K | ef20078724_8k.htm |
| 2026-07-21 | SC 14D9/A | ef20078316_sc14d9a.htm |
| 2026-07-17 | SC 14D9/A | ef20078177_sc14d9a.htm |
| 2026-07-17 | 8-K | ef20078184_8k.htm |
| 2026-07-13 | SC 14D9/A | ef20077863_sc14d9a.htm |
| 2026-07-02 | SC 14D9/A | ef20077296_sc14d9a.htm |
| 2026-06-10 | SC 14D9 | ny20069664x1_sc14d9.htm |
| 2026-06-09 | 8-K | ef20075787_8k.htm |